Ludo J Vanopdenbosch

Prof. Dr. Ludo J Vanopdenbosch


Research Focus & Metrics

Academic Career Length

22Years (2005-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
20 June 2010 in Journal of Neurology, Neurosurgery & Psychiatry
Verified
Journal Article
Closed access
PDF file
LVLudo J Vanopdenbosch
Ludo J Vanopdenbosch
PDPeter Dedeken
Peter Dedeken
JCJ. W. Casselman
J. W. Casselman
SVStephan A P A Vlaminck
Stephan A P A Vlaminck
Objectives The techniques currently used to detect a cerebrospinal fluid (CSF) leak are an indium radionucleotide scan and a CT scan with intrathecal iodinated contrast agent. They have a low spatial and temporal resolution and are unpleasant for the patient. This open-label prospective observational cohort study was designed to investigate the feasibility, success ratio, complications and therapeutic consequences of MRI with gadolinium administered by lumbar puncture to detect a CSF leak. Methods Patients were selected with either confirmed liquorrhoea, recurrent bacterial meningitis, or symptoms, and MRI findings of spontaneous intracranial hypotension. High-resolution T1 weighted MRI with fat suppression of the spinal column at 1 h and of the brain at 6 and 24 h postinjection of 0.5 ml of gadolinium were performed. Results 27 patients were included. The clinically suspected CSF leak was found in six of eight patients with liquorrhoea, three of five patients with recurrent bacterial meningitis and nine of 14 patients with spontaneous intracranial hypotension. The procedure was easy to perform and generally well tolerated. One patient developed streptococcal meningitis in the hours following the procedure but recovered completely with antibiotic treatment. 17 of 18 patients in whom a dural defect was found underwent surgery. All patients became symptom-free after closure of the dural leak. Conclusions Spinal cord and brain MRI after intrathecal gadolinium injection is an easy-to-perform and accurate technique for detection of a dural defect with excellent anatomical detail.

1 July 2005 in Journal of Neurology, Neurosurgery & Psychiatry
Verified
Journal Article
Open access
PDF file
LVLudo J Vanopdenbosch
Ludo J Vanopdenbosch
KVK Verhoeven
K Verhoeven
JCJ W Casselman
J W Casselman
Bell’s palsy is an idiopathic facial palsy of the peripheral type. A herpes virus is the most likely mechanism. We report a patient with the often encountered combination of a facial palsy with ipsilateral sensory changes. Magnetic resonance imaging showed had contrast enhancement in the greater petrosal nerve. Viral spread through anatomical connections could be an explanation for the association of facial palsy with numbness.

1 March 2014 in Multiple Sclerosis and Related Disorders
Verified
Journal Article
Closed access
AVAlexander Verhaeghe
Alexander Verhaeghe
ODOlivier Maurice Deryck
Olivier Maurice Deryck
LVLudo J Vanopdenbosch
Ludo J Vanopdenbosch

13 February 2007 in The Journal of Laryngology & Otology
Verified
Journal Article
Closed access
PDF file
BLB Lerut
B Lerut
CVC De Vuyst
C De Vuyst
JGJ Ghekiere
J Ghekiere
LVLudo J Vanopdenbosch
Ludo J Vanopdenbosch
RKR Kuhweide
R Kuhweide
Following trauma to her right frontal region, a 68-year-old woman suffered bilateral, benign, paroxysmal, positional vertigo and a left-sided, longitudinal petrosal bone fracture, with secondary facial palsy and ossicular luxation. From the onset, the patient complained of pulsatile, left-sided tinnitus. After eight weeks, she developed left-sided ocular symptoms, progressing from conjunctival hyperaemia and orbital oedema to an abducens nerve palsy, and ultimately to heart failure.The case and the final diagnosis of carotico-cavernous fistula are discussed. Guidelines are proposed for a diagnostic approach to pulsatile tinnitus and for the optimal management of patients presenting with pulsatile tinnitus associated with ocular symptoms.

25 January 2014 in Trials
Verified
Journal Article
Open access
PDF file
MCMelissa Cambron
Melissa Cambron
JMJop Mostert
Jop Mostert
PHPatrick Haentjens
Patrick Haentjens
MDMarie B. D’hooghe
Marie B. D’hooghe
GNGuy Nagels
Guy Nagels
JKJacques De Keyser
Jacques De Keyser
Currently available disease-modifying treatments acting by modifying the immune response are ineffective in progressive multiple sclerosis (MS), which is caused by a widespread axonal degeneration. Mechanisms suspected to be involved in this widespread axonal degeneration are reduced axonal energy metabolism, axonal glutamate toxicity, and reduced cerebral blood flow. Fluoxetine might theoretically reduce axonal degeneration in MS because it stimulates energy metabolism through enhancing glycogenolysis, stimulates the production of brain-derived neurotrophic factor, and dilates cerebral arterioles. The current document presents the protocol of a clinical trial to test the hypothesis that fluoxetine slows down the progressive phase of MS. The FLUOX-PMS trial is a multi-center, randomized, controlled and double-blind clinical study. A total of 120 patients with the diagnosis of either secondary or primary progressive MS will be treated either by fluoxetine (40 mg daily) or placebo for a total period of 108 weeks. The primary endpoint is the time to confirmed disease progression defined as either at least a 20% increase in the timed 25-Foot Walk or at least a 20% increase in the 9-Hole Peg Test. Secondary endpoints include the Hauser ambulation index, cognitive changes, fatigue, magnetic resonance imaging of the brain, and in a small subgroup optical coherence tomography. The FLUOX-PMS trial will gives us information as to whether fluoxetine has neuroprotective effects in patients with progressive MS. Eudra-CT: 2011-003775-11

10 July 2013 in Case Reports in Neurological Medicine
Verified
Journal Article
Open access
PDF file
SBSofie N. De Blauwe
Sofie N. De Blauwe
PSPatrick Santens
Patrick Santens
LVLudo J Vanopdenbosch
Ludo J Vanopdenbosch
We describe a 66-year-old woman who presented with a dramatic course of PERM. Anti-glycine receptor antibodies were found. She stabilized after plasma-exchange and partly recovered. Eighteen months later, a diagnosis of smouldering breast cancer with bone marrow metastasis was made. There are indications that this tumor was already present at first presentation. An overview of PERM and anti-glycine receptor antibodies is given.